Home/Pipeline/E-vita Open NEO Hybrid Stent Graft System

E-vita Open NEO Hybrid Stent Graft System

Complex Aortic Arch Disease

CommercialApproved (Custom-Made)

Key Facts

Indication
Complex Aortic Arch Disease
Phase
Commercial
Status
Approved (Custom-Made)
Company

About Artivion

Artivion is a global medical device company dedicated to advancing the treatment of aortic diseases through a focused portfolio of surgical and endovascular solutions. The company's strategic acquisitions, including Ascyrus Medical and the On-X heart valve technology, have positioned it as a leader in aortic arch repair and mechanical heart valves. With over 1,600 employees worldwide, Artivion is driving patient-powered progress by collaborating with surgeons to address their most difficult challenges, supported by a robust clinical pipeline and recent regulatory milestones like the FDA HDE for its AMDS device.

View full company profile